SCIENTURE HOLDINGS, INC. Other Current Liabilities
SCIENTURE HOLDINGS, INC. (SCNX) had Other Current Liabilities of $5.44 thousand as of 2025-06-30, per its 10-Q filed 2025-08-12.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2026-03-30
- 2025-06-30: Other Liabilities, Current $5.44K.
- 2025-03-31: Other Liabilities, Current $5.44K.
- 2024-12-31: Other Liabilities, Current $5.44K.
- 2024-09-30: Other Liabilities, Current $5.44K.
| Period end | Other Liabilities, Current | Other Liabilities, Current as first filed |
|---|---|---|
| 2025-06-30 | $5.44K 10-Q · filed 2025-08-12 | |
| 2025-03-31 | $5.44K 10-Q · filed 2025-05-12 | |
| 2024-12-31 | $5.44K 10-K · filed 2026-03-30 | |
| 2024-09-30 | $5.44K 10-Q · filed 2024-11-06 | |
| 2024-06-30 | $5.44K 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $5.44K 10-Q · filed 2024-06-26 | |
| 2023-12-31 | $67.83K 10-K · filed 2025-03-26 | $70.31K 10-K · filed 2024-04-22 |
| 2023-09-30 | $412.39K 10-Q · filed 2024-01-16 | |
| 2023-06-30 | $792.08K 10-Q · filed 2023-08-18 | |
| 2023-03-31 | $229.16K 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $67.52K 10-K · filed 2024-04-22 | |
| 2022-09-30 | $105.93K 10-Q · filed 2022-11-07 | |
| 2022-06-30 | $14.20K 10-Q · filed 2022-07-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |